Novo Nordisk A/S (NVO)
44.74
-1.06
(-2.31%)
USD |
NYSE |
May 15, 16:00
44.45
-0.29
(-0.65%)
After-Hours: 20:00
Novo Nordisk EPS Diluted (Quarterly) : 1.709 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.9849 |
| GSK Plc | 1.149 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Lexicon Pharmaceuticals, Inc. | -0.0026 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.604B |
| Revenue (Quarterly) | 15.16B |
| Total Expenses (Quarterly) | 7.558B |
| Enterprise Value | 217.56B |
| Gross Profit Margin (Quarterly) | 85.96% |
| Profit Margin (Quarterly) | 50.15% |
| Earnings Yield | 9.52% |
| Operating Earnings Yield | 11.63% |
| Normalized Earnings Yield | 9.525 |